![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/29 | |
A61K 33/10 | |||
A61P 19/08 | |||
A61P 19/10 | |||
A61P 43/00 |
(11) | Number of the document | 2476429 |
(13) | Kind of document | T |
(96) | European patent application number | 10815369.3 |
Date of filing the European patent application | 2010-09-08 | |
(97) | Date of publication of the European application | 2012-07-18 |
(45) | Date of publication and mention of the grant of the patent | 2018-03-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2010/065379 |
Date | 2010-09-08 |
(87) | Number | WO 2011/030774 |
Date | 2011-03-17 |
(30) | Number | Date | Country code |
2009208039 | 2009-09-09 | JP |
(72) |
SHIRAE Shinichiro, JP
NAKAMURA Yasuo, JP
OYA, Yuiko, JP
NOZAKI Yoshihide, JP
KOBAYASHI Nobuyuki, JP
KURODA Tatsuhiko, JP
KATO Hiroki, JP
SERADA Masashi, JP
HORI Kazuyoshi, JP
|
(73) |
Asahi Kasei Pharma Corporation,
1-105 Kanda Jinbocho Chiyoda-ku, Tokyo 101-8101,
JP
|
(54) | PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK AT UNIT DOSE OF 200 UNITS |
PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK AT UNIT DOSE OF 200 UNITS |